Novartis AG
NVSNYSEPharmaceutical PreparationsFiscal year ends December 31Also trades as NVSEF
$161.52+0.73 (+0.45%)
Close on Nov 2, 2026Market cap $308.20BP/E 22.6Yield –
Novartis Non-Current Financial Debts: $27,935M in FY2025, up 30.7% from a year earlier. That is the highest of the 8 years on record here.
Latest, FY2025
27,935
Period ended Dec 31, 2025
Change on a year earlier
+30.7%
21,366 in FY2024
History
8 years
Since FY2018
Sources
8
Documents cited below
Where the FY2025 figure comes from
“|| Financial debts | 36 699 | 27 935”
Source: Novartis Form 6-K (0001114448-26-000014) ↗
Reported in Form 6-K.
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Non-Current Financial Debts ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 27,935 | +30.7% | Novartis Form 6-K (0001114448-26-000014) ↗ |
| FY2024 | Dec 31, 2024 | 21,366 | +15.9% | Novartis Form 6-K (0001114448-25-000003) ↗ |
| FY2023 | Dec 31, 2023 | 18,436 | -8.9% | Novartis Form 6-K (0001370368-24-000022) ↗ |
| FY2022 | Dec 31, 2022 | 20,244 | -11.6% | Novartis Form 6-K (0001370368-23-000068) ↗ |
| FY2021 | Dec 31, 2021 | 22,902 | -12.8% | Novartis Form 6-K (0001370368-22-000077) ↗ |
| FY2020 | Dec 31, 2020 | 26,259 | +29.0% | Novartis Form 6-K (0001370368-21-000072) ↗ |
| FY2019 | Dec 31, 2019 | 20,353 | -9.4% | Novartis Form 6-K (0001370368-20-000086) ↗ |
| FY2018 | Dec 31, 2018 | 22,470 | – | Novartis Form 6-K (0001370368-19-000062) ↗ |
Cite this data
StockData. (2026). Novartis Non-Current Financial Debts ($M), annual FY2018–FY2025 [Data set]. Compiled from Novartis SEC filings and investor materials. https://stockdatahq.com/stocks/nvs/kpis/db-bs-lt-debt
See every metric in the Novartis KPI table. Data updated Nov 2, 2026.